Check out these resources that are easy to share with patients at your office!
If you’re interested in receiving print versions at no cost, please use our resource order form!
Contact WUN by emailing info@wakeupnarcolepsy.org for appeal letter templates for when prior authorization has been denied
Thank you to our 2025 HCP Resource Sponsors:
Diamond Champion Sponsors:
Gold Champion Sponsors:
Program Sponsors:
This activity is jointly provided by Medical Education Resources (MER) and Efficient LLC and was developed in collaboration with Wake Up Narcolepsy (WUN)
This activity is supported by independent medical education grants from Harmony Biosciences and Jazz Pharmaceuticals.
Released: November 24, 2025
Expires: November 24, 2026
Faculty: Anne Marie Morse, DO, FAASM, Logan Schneider, MD
Program Description:Though excessive daytime sleepiness (EDS) is the hallmark symptom of narcolepsy, both type 1 (NT-1) and type 2 (NT-2), these patients present with a variety of diverse clinical symptoms that extend well beyond EDS, often leading to prolonged diagnostic journeys and fragmented care. Recent approvals of novel pharmacologic agents have transformed the therapeutic armamentarium, but individualized implementation is essential to optimize outcomes. This educational initiative integrates the perspectives of a cohort of patients diagnosed with NT-1 and NT-2 to illuminate the lived experience of these individuals to highlight how their insights may help to expedite and refine the identification and management of this group. Two leading sleep medicine specialists further contextualize these findings, discussing the evolving therapeutic landscape and practical strategies to translate patient insights into improved clinical decision-making.
Provider: SleepWorld Magazine and SleepRes
Supported by Wake Up Narcolepsy (WUN), Persante Healthcare, Sunset Healthcare Solutions, VieMed and MedBridge Healthcare
Speakers: Peter Gay, MD, William Noah, MD, & David P. White, MD
Program Description: Meet the Professors and the Inventor in this 90-minute webinar with 1.5 CME/CE/CEU credits composed of three 25-minute presentations with discussion to follow.
First, Peter Gay, MD (Professor of Medicine at the Mayo Clinic) will review 30 years of randomized trials with BPAP and expiratory pressure reduction (EPR) algorithms failing to increase adherence over CPAP, and present when higher IPAP is actually needed.
Second, William H. Noah, MD (inventor of V-Com® and KairosPAP™ or KPAP™), will discuss the history, physics, and physiology of positive airway pressure (PAP) therapy and how current CPAP and bilevel PAP (BPAP) devices are engineered with the wrong understanding of OSA.
Finally, David P. White, MD (former editor-in-chief of SLEEP, AASM President, and Professor of Medicine at Harvard Medical School) will review the results of six recent clinical trials with either V-Com or KPAP providing the same efficacy as CPAP despite reducing the IPAP as much as 5 cmH2O below EPAP with much more comfort, increased usage time, and decreased side effects.
A Q&A session will follow the presentation.

Provider: USF Health & PeerVoice endorsed by Wake Up Narcolepsy (WUN)
This program is supported by an independent medical education grant from Jazz Pharmaceuticals.
Released: June 25, 2024
Course Director: Phyllis C. Zee, MD, PhD
Faculty: Barbara Hutchinson, MD, PhD, FACC & Michael Grandner, PhD, MTR, DBSM
Intended Audience: This activity has been designed to meet the educational needs of neurologists, psychiatrists, sleep specialists, pulmonologists, and other clinicians involved in the management of narcolepsy.
Activity Description: In this activity, experts examine the link between narcolepsy and cardiovascular risk and explore strategies to protect the cardiovascular health of individuals with narcolepsy.